Resistant Pseudomonas Aeruginosa Infections - Pipeline Review, H2 2016; New Report Launched
Resistant Pseudomonas aeruginosa Infections – Pipeline Review, H2 2016'; Resistant Pseudomonas aeruginosa Infections pipeline therapeutics constitutes close to 21 molecules. Out of which approximately 20 molecules are developed by Companies and remaining by the Universities/Institutes.
View full press release